+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Pruritus Therapeutics Market Report 2025 - Product Thumbnail Image

Pruritus Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Intravenous (IV) Solutions Market 2024-2028 - Product Thumbnail Image

Intravenous (IV) Solutions Market 2024-2028

  • Report
  • July 2024
  • 157 Pages
  • Global
From
From
Intravenous Solutions Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Intravenous Solutions Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Iron Deficiency Injectable Market Report 2025 - Product Thumbnail Image

Iron Deficiency Injectable Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Intravenous (IV) Hydration Therapy Market Report 2025 - Product Thumbnail Image

Intravenous (IV) Hydration Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Chemotherapy-Induced Anemia Market Report 2025 - Product Thumbnail Image

Chemotherapy-Induced Anemia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Intravenous Solutions Market Report and Forecast 2023-2031 - Product Thumbnail Image

Intravenous Solutions Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
From
Loading Indicator